Loading…
NEW NIKKOMYCINS BY MUTASYNTHESIS AND DIRECTED FERMENTATION
The nikkomycins, nucleoside peptide antibiotics, produced by Streptomyces tendae inhibit the chitin syntheses of fungi and insects. Uracil and 4-formyl-4-imidazoline-2-one are the variable bases of the natural nikkomycins. Since uracil originates from the pyrimidine metabolism, pyr mutants, which ar...
Saved in:
Published in: | Journal of antibiotics 1984, Vol.37(1), pp.80-82 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The nikkomycins, nucleoside peptide antibiotics, produced by Streptomyces tendae inhibit the chitin syntheses of fungi and insects. Uracil and 4-formyl-4-imidazoline-2-one are the variable bases of the natural nikkomycins. Since uracil originates from the pyrimidine metabolism, pyr mutants, which are not able to form uracil, produce only nikkomycins with the 4-formyl-4-imidazoline-2-one base. Twenty-three N-heterocyclic compounds, including pyrimidines, purines and imidazoles, were fed to the nikkomycin producer (directed fermentation) and to the pyr mutants descended from it (mutasynthesis). Upon administration of the three pyrimidine - thymine, 5-hydroxymethyluracil and 5-formyluracil - interesting additional peaks were detected in the HPLC. To qualify as new nikkomycins the peaks must have certain characteristics: pH stability and binding to cation and anion exchange resins. Furthermore, the sequence of the nikkomycins in the HPLC corresponds to that of their bases, and from one base both nikkomycin Z- and J-analogues are produced. Isoorotic acid, another base, did not show any new peaks; instead, production of nikkomycins Z and J was increased. The combination of high voltage electrophoresis with various biological tests and HPLC analysis showed that a new weakly active nikkomycin was produced. |
---|---|
ISSN: | 0021-8820 1881-1469 |
DOI: | 10.7164/antibiotics.37.80 |